Sensei Biotherapeutics In...

NASDAQ: SNSE · Real-Time Price · USD
8.68
1.18 (15.73%)
At close: Aug 15, 2025, 3:59 PM
8.80
1.38%
After-hours: Aug 15, 2025, 07:56 PM EDT

Sensei Biotherapeutics Cash Flow Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Net Income
-4.94M -6.86M -7.77M -7.25M -7.14M -7.99M -7.41M -7.12M -9.39M -10.18M -12.23M -13.42M -10.54M -12.4M -9.37M -9.69M -9.77M -7.97M
Depreciation & Amortization
37K 34K 331K 332K n/a 137K 135K 332K 332K 358K 351K 342K 320K 334K 329K 136K 122K 98K
Stock-Based Compensation
264K 461K 391K 733K 795K 1.22M 1.1M 1.05M 1.09M 1.21M 1.4M 1.48M 1.42M 1.51M 826K 1.74M 1.75M 1.35M
Other Working Capital
1.97M -1.97M 250K 1.67M 85K -1.73M 381K 508K 548K -3.44M -1.36M 2.31M -848K -3.31M 1.11M 1.85M 949K -2.37M
Other Non-Cash Items
-2.13M 134K 1.01M -624K 470K 1.63M 62K 318K 353K 64K 253K 247K 422K 473K 51K 1K 2K 3K
Deferred Income Tax
n/a n/a n/a n/a n/a n/a 356K -214K -142K n/a n/a n/a n/a n/a 199K -353K 173K n/a
Change in Working Capital
859K -859K 250K 1.34M 85K -1.43M -400K 979K -1.72M -3.19M 655K 4.54M -3.52M -667K 93K 2.59M 1.68M -4.25M
Operating Cash Flow
-5.91M -7.09M -5.79M -5.47M -5.79M -7.62M -6.16M -4.66M -9.46M -11.74M -9.57M -6.8M -11.9M -10.75M -7.87M -5.58M -6.05M -10.77M
Capital Expenditures
-16K n/a n/a n/a -109K -37K n/a n/a -29K -151K -71K -250K -52K -19K -535K -388K -616K -487K
Cash Acquisitions
n/a n/a n/a n/a n/a n/a -166K n/a 157K n/a n/a 15K -13.25K n/a -120.89M n/a n/a n/a
Purchase of Investments
-2.44M -6.35M -17.77M -8.84M -11.73M -6.26M -2.61M -8.69M -2K -9.85M 18.15M -21.75M -35.25M -8.02M -9.85M -26.67M -147.15M n/a
Sales Maturities Of Investments
11M 13.5M 14.62M 21.75M 18.75M 12.07M 10.88M 17M 19.4M 12.3M -2.1M 30.5M 48.5M 20.23M 16M 26.26M n/a n/a
Other Investing Acitivies
210K 40K n/a n/a n/a 5.81K 166K 8.31K 19.55K 9K 71K 8.77K 13.25K 12.21K 120.89M 26.58M -147.15M n/a
Investing Cash Flow
8.76M 7.19M -3.15M 12.91M 6.91M 5.77M 8.26M 8.31M 19.53M 2.31M 16.04M 8.52M 13.2M 12.19M 5.61M -482K -147.76M -487K
Debt Repayment
n/a n/a -207K -204K -201K -199K -196K -190K -189K -186K -177K -163K -156K -133K -227K -7K -11K -10K
Common Stock Repurchased
n/a n/a n/a 10.00 n/a -10 -252K -2.34M -7.79M n/a n/a n/a n/a n/a n/a n/a n/a n/a
Dividend Paid
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Financial Acitivies
-168K -214K 13K n/a 21K -10K -31K n/a 31K -76K 53K n/a 37K 252K 108K n/a n/a 1K
Financial Cash Flow
-168K -214K -194K -204K -180K -209K -431K -2.53M -7.95M -262K -124K -163K -119K 119K -118 -7 -11 164.08K
Net Cash Flow
2.68M -117K -9.14M 7.24M 935K -2.06M 1.67M 1.12M 2.12M -9.69M 6.34M 1.55M 1.18M 1.56M -2.37M -6.07M -153.82M 152.82M
Free Cash Flow
-5.92M -7.09M -5.79M -5.47M -5.9M -7.65M -6.16M -4.66M -9.49M -11.89M -9.64M -7.05M -11.95M -10.77M -8.4M -5.96M -6.66M -11.25M